查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571644

美國快速門診市場規模、佔有率、趨勢分析報告：按業主、診斷、地區和細分市場預測，2024-2030 年

U.S. Retail Clinics Market Size, Share & Trends Analysis Report By Ownership (Retail Owned, Hospital Owned), By Diagnosis (Immunization, General Symptoms, General Screening & Examination, Injuries), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

美國快速門診市場成長與趨勢：

Grand View Research, Inc.的最新報告顯示，到2030年，美國快速門診市場規模預計將達到68.6億美元。

預計2024年至2030年該市場將以9.7%的複合年成長率成長。便捷的交通和實惠的價格預計將推動美國快速門診市場的成長。

這些機構作為提供基層醫療的替代管道，以可負擔的價格提供基本醫療保健服務，減少了就診醫療保健部門的需求。在美國，大約 10% 的急診就診是在急診外接受治療的。這可以減少您去急診室就診時的自付費用。

這些醫療機構通常每週 7 天開放。此外，等待時間很短並且不需要預訂。診所位於便利商店或商場內，交通便利，就診時間靈活，方便使用。

此外，電子病歷等資訊科技的引入有助於維護簡化的病患記錄，這些記錄可以在不同的醫療保健系統之間共用。此類患者資料還可用於實施人口健康管理策略，以改善患者治療結果，並可促進美國醫療保健從按服務收費 (FFS) 模式向基於價值的護理模式的轉變。

美國快速門診市場報告亮點

  • 到 2023 年，零售商自有細分市場將佔據市場主導地位，市場佔有率將達到 81.8%。 CVS Health 等公司擁有、經營和管理 MinuteClinic 診所。
  • 2023年，免疫領域佔市場最大銷售佔有率，為25.3%。據觀察，在 COVID-19 大流行期間和之後，快速門診市場越來越受到人們疫苗接種的歡迎，因為這些診所也提供檢測設施。
  • 2023 年，東南地區的收益佔有率最大，達 34.2%。這是由於該地區擴大使用便利的非緊急醫療服務。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章美國快速門診市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國快速門診市場分析工具
    • 波特的分析
    • PESTEL分析

第4章美國快速門診市場：業主估計和趨勢分析

  • 細分儀表板
  • 美國快速門診市場：2023 年和 2030 年按所有權變化分析
  • 擁有零售店
  • 醫院擁有

第5章美國快速門診市場：按診斷估計和趨勢分析

  • 細分儀表板
  • 美國快速門診市場：2023 年和 2030 年診斷變化分析
  • 免疫
  • 常見症狀
  • 受傷
  • 一般篩檢和測試
  • 急性呼吸道疾病及感染疾病
  • 尿道感染
  • 耳部感染疾病
  • 扭傷、拉傷、骨折
  • 其他

第6章美國快速門診市場：區域估計和趨勢分析

  • 2023 年及 2030 年美國快速門診市場佔有率（按地區）
  • 東南
  • 中西部
  • 西南
  • 東北
  • 西方

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • CVS Health
    • Kroger Health
    • Walgreens
    • Advocate Health Care
    • Kaiser Foundation Health Plan, Inc.
    • Walmart
    • Bellin Health Systems
    • Geisinger Health
    • Target
簡介目錄
Product Code: GVR-1-68038-615-8

U.S. Retail Clinics Market Growth & Trends:

The U.S. retail clinics market size is anticipated to reach USD 6.86 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.7% from 2024 to 2030. Convenient access and affordable prices are expected to boost growth of the U.S. retail clinics market.

These settings act as an alternate channel for provision of primary care and offer basic healthcare services at affordable prices, lowering the need to visit the Emergency Department. Around 10% of the visits to the emergency departments in the U.S. could be treated outside of the ED. This reduces the out-of-pocket costs paid for the visit to an ED.

These settings usually operate during all seven days of a week. In addition, they have shorter waiting duration and appointments are not mandatory. Convenience and flexibility of visit hours help people easily access clinics that are located in grocery stores, shopping malls, and other locations.

In addition, adoption of information technology, highlighted by the use of EHRs helps these settings maintain a streamlined patient record that can be shared across different healthcare systems. This patient data could also be used to implement population health management strategies, for better patient outcomes, which could ease the U.S. healthcare's transformation into a value-based care model from a fee-for-service (FFS) model.

U.S. Retail Clinics Market Report Highlights:

  • Retail owned segment dominated the market with a share of 81.8% in 2023. Companies such as CVS Health, own, operate, or provide management for its MinuteClinic clinics.
  • Immunization segment held the largest revenue share of 25.3% of the market in 2023. During and after the COVID-19 pandemic, the retail clinics market observed increasing popularity among people for vaccinations as these clinics provided the testing facilities as well.
  • The Southeast region witnessed the largest revenue share of 34.2% in 2023 owing to the increasing utilization of accessible & non-emergency healthcare services in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Retail Clinics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. U.S. Retail Clinics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. U.S. Retail Clinics Market: Ownership Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Retail Clinics Market: Ownership Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Retail Owned
    • 4.3.1. Retail Owned Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 4.4. Hospital Owned
    • 4.4.1. Hospital Owned Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)

Chapter 5. U.S. Retail Clinics Market: Diagnosis Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Retail Clinics Market: Diagnosis Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Immunization
    • 5.3.1. Immunization Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.4. General Symptoms
    • 5.4.1. General Symptoms Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.5. Injuries
    • 5.5.1. Injuries Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.6. General Screening & Examination
    • 5.6.1. General Screening & Examination Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.7. Acute Respiratory Disease & Infection
    • 5.7.1. Acute Respiratory Disease & Infection Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.8. Urinary Tract Infections
    • 5.8.1. Urinary Tract Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.9. Ear Infections
    • 5.9.1. Ear Infections Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.10. Sprains, Strains, and Fractures
    • 5.10.1. Sprains, Strains, and Fractures Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Others Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)

Chapter 6. U.S. Retail Clinics Market: Regional Estimates & Trend Analysis

  • 6.1. U.S. Retail Clinics Market Share, By Region, 2023 & 2030, USD Million
  • 6.2. Southeast
    • 6.2.1. Southeast U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 6.3. Midwest
    • 6.3.1. Midwest U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 6.4. Southwest
    • 6.4.1. Southwest U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 6.5. Northeast
    • 6.5.1. Northeast U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 6.6. West
    • 6.6.1. West U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. CVS Health
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Kroger Health
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Walgreens
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Advocate Health Care
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Kaiser Foundation Health Plan, Inc.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Walmart
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Bellin Health Systems
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Geisinger Health
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Target
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives